Blood tests could spot pancreas cancer sooner
NCT ID NCT03568630
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is following 1,250 people at higher risk for pancreas cancer, including those with new diabetes, pancreatic cysts, or a family history. Researchers will collect blood samples and health data twice a year for several years. The goal is to find early markers in the blood that could lead to faster diagnosis and better survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a blood test that catches pancreas cancer earlier, when it's more treatable.
- What could go wrong
- This is an observational study, not a treatment trial. It may take years to find reliable markers, and results might not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Unversity of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68198, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new rice could tame blood sugar spikes in prediabetes
- Blood and gut clues may flag pancreatic cancer risk early
- Can a heart drug tame blood sugar and weight in diabetes?
- Could everyday supplements turn back the clock on aging?
- Can a single pill tackle both fatty liver and diabetes?
- Can a puff of insulin replace a needle for diabetes?